Literature DB >> 9660751

Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanism.

P S Kingma1, N Osheroff.   

Abstract

The interaction of topoisomerase II with its DNA cleavage site is critical to the physiological functions of the enzyme. Despite this importance, the specific enzyme-DNA interactions that drive topoisomerase II-mediated DNA cleavage and religation are poorly understood. Therefore, to dissect interactions between the enzyme and its cleavage site, abasic DNA lesions were incorporated into a bilaterally symmetrical and identical cleavage site. Results indicate that topoisomerase II has unique interactions with each position of the 4-base overhang generated by enzyme-mediated DNA cleavage. Lesions located 2 bases 3' to the point of scission stimulated cleavage the most, whereas those 3 bases from the point of scission stimulated cleavage the least. Moreover, an additive and in some cases synergistic cleavage enhancement was observed in oligonucleotides that contained multiple DNA lesions, with levels reaching >60-fold higher than the wild-type substrate. Finally, topoisomerase II efficiently cleaved and religated a DNA substrate in which apyrimidinic sites were simultaneously incorporated at every position on one strand of the 4-base overhang. Therefore, unlike classical DNA ligases in which base pairing is the driving force behind closure of the DNA break, it appears that for topoisomerase II, the enzyme is responsible for the spatial orientation of the DNA termini for ligation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660751     DOI: 10.1074/jbc.273.29.17999

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

2.  Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions.

Authors:  M Sabourin; N Osheroff
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

3.  Direct and Topoisomerase II Mediated DNA Damage by Bis-3-chloropiperidines: The Importance of Being an Earnest G.

Authors:  Alice Sosic; Ivonne Zuravka; Nina-Katharina Schmitt; Angelica Miola; Richard Göttlich; Dan Fabris; Barbara Gatto
Journal:  ChemMedChem       Date:  2017-08-10       Impact factor: 3.466

4.  Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha.

Authors:  Joseph E Deweese; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2008-03-05       Impact factor: 3.162

Review 5.  Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.

Authors:  Yves Pommier; Yilun Sun; Shar-Yin N Huang; John L Nitiss
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-21       Impact factor: 113.915

Review 6.  Debulking of topoisomerase DNA-protein crosslinks (TOP-DPC) by the proteasome, non-proteasomal and non-proteolytic pathways.

Authors:  Yilun Sun; Liton Kumar Saha; Sourav Saha; Ukhyun Jo; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2020-07-10

7.  Long noncoding RNA NONMMUT015745 inhibits doxorubicin-mediated cardiomyocyte apoptosis by regulating Rab2A-p53 axis.

Authors:  Hongjing Cai; Pengchao Tian; Jie Ju; Tao Wang; Xinzhe Chen; Kai Wang; Fei Wang; Xue Yu; Shaocong Wang; Yin Wang; Chan Shan; Peifeng Li
Journal:  Cell Death Discov       Date:  2022-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.